Jian Li, Ting Xu, Weizhen Zhang, Wenbin Li, Zhuang Kang, Zhenchao Yuan, Wei Jiang, Xianan Li, Yongchang Zhang, De-zhi Kang, Ying Wang, Bing Xia, Jian Zhang, Yu Xu, Shikai Wu, Lin Shen. "A phase 1, multicenter, open-label study of HSK42360, a brain-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3109